Industry
Global Microbiology Diagnostic Devices and Equipment Market Driven by Emergence of Novel Pathogens
The global microbiology diagnostic devices and equipment market is expected to register a compound annual growth rate (CAGR) of 10.7% from USD 3.42 billion in 2021 to USD 5.69 billion in 2026 and grow further at a CAGR of 8.6% from 2026 to reach USD 8.56 billion in 2031. More...20 Feb 2023
DiaSorin’s Luminex Subsidiary to Spin Off Flow Cytometry Business to Cell Analysis Leader
DiaSorin and Cytek Biosciences have announced that Luminex, a wholly owned subsidiary of DiaSorin, has signed an agreement with Cytek to sell substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit. More...15 Feb 2023
Next-Generation Sequencing (NGS) Market Driven by Launch of Technologically Advanced Systems
The global next generation sequencing (NGS) market is projected to grow at a CAGR of 15.7% from USD 13 billion in 2022 to USD 27 billion by 2027, driven by the launch of technologically advanced NGS systems and improving regulatory and reimbursement scenarios for NGS-based diagnostic tests. More...10 Feb 2023
Global Hemostasis Analyzers Market Driven by Increasing Awareness of Blood Disorder Conditions
The global hemostasis analyzers market is expected to reach USD 5.97 billion in 2026, driven by the increasing awareness of blood disorder conditions such as Hemophilia and Von Willebrand disease (vWD) which are genetic disorders and not well known to people. This results in late diagnosis of blood disorders and affects patient outcomes. The increasing awareness is expected to improve the diagnosis rate of blood disorders, thereby driving the demand for hemostasis analyzers. More...09 Feb 2023
Chembio and Biosynex to Merge, Forging US-French Point-of-Care Testing Powerhouse
Biosynex SA, a French company specializing in the design and distribution of rapid tests, and Chembio Diagnostics, Inc., a leading point-of-care diagnostics company in the U.S. that is focused on infectious diseases, have entered into a definitive merger agreement under which Biosynex, through a subsidiary, will acquire Chembio in an all-cash transaction valued at USD 17.2 million. More...02 Feb 2023
CerTest to Run ‘More than Diagnostics’ Campaign Throughout 2023
CerTest Biotec has announced that the company will run its campaign ‘More than Diagnostics’ throughout 2023 in acknowledgement of the transformation that it has gone through, accelerated by the COVID-19 pandemic. CerTest’s ‘More than Diagnostics’ campaign expresses the company’s ambition to continue growing and advancing towards an exciting future, with people’s health remaining its key focus. More...01 Feb 2023
New Collaboration to Apply Power of AI to Digital Pathology Images
Clinical artificial intelligence (AI) applications have the potential to help pathologists diagnose cancer more confidently and efficiently, ultimately improving patient care. Now, a new collaboration aims to lead the digital transformation of pathology and cancer diagnosis. More...30 Jan 2023
.jpg)
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Pipette Calibration System
Artel PCS®
New
Pneumonia Test
Pneumocystis ELITe MGB® Kit
In Other News
Point-of-Care Glucose Testing Market to Reach Almost USD 6 Billion by 2032
Carolina Liquid Chemistries and Diazyme Enter Into Partnership
Siemens Launches Centre of Excellence for Immunoassay Instrument R&D in Ireland
Medlab Middle East Sees 100% Increase in Exhibitor Numbers
Thermo Fisher Completes Acquisition of UK’s Binding Site
Tianlong’s PCR Lab Solution Safeguards 2022 G20 Indonesia Summit
Tianlong Contributes to China’s Power to Prevent and Control Global Epidemics
Global Urinalysis Market Driven by Increasing Burden of UTIs, Diabetes, and Kidney & Liver Diseases
Fujifilm Enters Digital Pathology Space with Acquisition of Inspirata
Global POC Diagnostics Market Driven by Growing Demand for Portable and Handheld Near-Patient Devices
Global Microplate Readers Market Driven by Rising Incidence of Infectious Diseases
AI-Based Digital Pathology Solutions Market Driven by Benefits of More Precise and Reproducible Diagnoses
Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling
Roche Introduces Digital Health Solutions Under Navify Brand
Werfen to Acquire Transfusion and Transplant Diagnostics Innovator for Around USD 2 Billion
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
AI-Enabled Diagnostic Testing Could Become More Accurate and Reliable than Current Tests
Global Infectious Respiratory Disease Diagnostics Market Driven by New Multiplex PCR Tests and POC Products
UK's Binding Site to Be Acquired by Thermo Fisher for USD 2.6 Billion
Nova Primary Blood Glucose Reference Analyzer Receives US FDA Clearance
AACC Middle East to Showcase Latest in Laboratory Medicine and Diagnostic Innovations
Global Lateral Flow Assay Market Driven by Rising Incidence of Infectious Diseases
Global Multiplex Detection Immunoassays Market Driven by Demand for Clinical Diagnostic Applications
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
